Advances in Clinical Chemistry. Volume 106

Table of Contents

1. Advances in ADAMTS biomarkers
Rahel Schnellmann
2. Advances in fibrosis biomarkers in nonalcoholic fatty liver disease
Stefano Ciardullo and Gianluca Perseghin
3. Metabolomics of peripheral artery disease
Ahmed Ismaeel, Ramon Lavado, and Panagiotis Koutakis
4. Molecular and cellular functions of long non-coding RNAs in prostate and breast cancer
Yuan-Shan Zhu and Jifeng Zhu
5. Myostatin: Basic biology to clinical application
Pasquale Esposito, Daniela Picciotto, Yuri Battaglia, Francesca Costigliolo, Francesca Viazzi, and Daniela Verzola
6. Metadherin (AEG-1/MTDH/LYRIC) expression: Significance in malignancy and crucial role in colorectal cancer
Muhammad T. Abdel Ghafar and Nema A. Soliman

Authors

Gregory S. Makowski Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA. Dr Gregory S Makowski is a board certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in his joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President and Chief Scientific Officer for Clinical Laboratory Partners in Newington CT, USA.